Literature DB >> 12032777

Myeloid differentiation (MyD) primary response genes in hematopoiesis.

Dan A Liebermann1, Barbara Hoffman.   

Abstract

Myeloid Differentiation (MyD) primary response and Growth Arrest DNA-Damage (Gadd) genes comprise a set of overlapping genes, including known (IRF-1, EGR-1, Jun) and novel (MyD88, Gadd45alpha MyD118/Gadd45beta, GADD45gamma, MyD116/Gadd34) genes, that have been cloned by virtue of there being co-ordinately induced upon the onset of terminal myeloid differentiation. This review delineates the role MyD genes play in blood cell development, where they function as positive regulators of terminal differentiation, lineage specific blood cell development and control of blood cell homeostasis, including growth inhibition and apoptosis.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12032777     DOI： 10.1038/sj.onc.1205312

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  13 in total

1.  Microarray analysis of Aeromonas hydrophila cytotoxic enterotoxin-treated murine primary macrophages.

Authors:  C L Galindo; A A Fadl; J Sha; A K Chopra
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

2.  Phosphorylation of Atg5 by the Gadd45β-MEKK4-p38 pathway inhibits autophagy.

Authors:  E Keil; R Höcker; M Schuster; F Essmann; N Ueffing; B Hoffman; D A Liebermann; K Pfeffer; K Schulze-Osthoff; I Schmitz
Journal:  Cell Death Differ       Date:  2012-10-12       Impact factor: 15.828

3.  Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.

Authors:  Xiaoyan Liu; Christine Happel; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells.

Authors:  Juan Liao; Sean E Humphrey; Stacie Poston; Elizabeth J Taparowsky
Journal:  Mol Cancer Res       Date:  2011-02-04       Impact factor: 5.852

5.  Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development.

Authors:  Erika W Lamb; Colleen D Walls; John T Pesce; Diana K Riner; Sean K Maynard; Emily T Crow; Thomas A Wynn; Brian C Schaefer; Stephen J Davies
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

6.  In the Crosshairs: NF-κB Targets the JNK Signaling Cascade.

Authors:  Can G Pham; Salvatore Papa; Concetta Bubici; Francesca Zazzeroni; Guido Franzoso
Journal:  Curr Med Chem Anti Inflamm Anti Allergy Agents       Date:  2005-12-01

7.  Sildenafil augments early protective transcriptional changes after ischemia in mouse myocardium.

Authors:  Ramesh Vidavalur; Suresh Varma Penumathsa; Mahesh Thirunavukkarasu; Lijun Zhan; Winfried Krueger; Nilanjana Maulik
Journal:  Gene       Date:  2008-10-25       Impact factor: 3.688

8.  MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells.

Authors:  Gomaa Sulaiman; Aoife Cooke; Brendan Ffrench; Claudia Gasch; Olayemi Azeez Abdullai; Kevin O'Connor; Salah Elbaruni; Gordon Blackshields; Cathy Spillane; Helen Keegan; Victoria McEneaney; Ronan Knittel; Annamarie Rogers; Ian B Jeffery; Brendan Doyle; Mark Bates; Charles d'Adhemar; Mathia Yc Lee; Eric L Campbell; Paul N Moynagh; Desmond G Higgins; Sharon O'Toole; Luke O'Neill; John J O'Leary; Michael F Gallagher
Journal:  Cell Death Differ       Date:  2017-09-08       Impact factor: 15.828

9.  Activator protein-1 transactivation of the major immediate early locus is a determinant of cytomegalovirus reactivation from latency.

Authors:  Benjamin A Krishna; Amanda B Wass; Christine M O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-11       Impact factor: 11.205

10.  Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach.

Authors:  Barbara Depreter; Barbara De Moerloose; Karl Vandepoele; Anne Uyttebroeck; An Van Damme; Eva Terras; Barbara Denys; Laurence Dedeken; Marie-Françoise Dresse; Jutte Van der Werff Ten Bosch; Mattias Hofmans; Jan Philippé; Tim Lammens
Journal:  Pediatr Res       Date:  2020-10-17       Impact factor: 3.756
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.